Novel insights into the therapeutic mode of action of recombinant FVIIa

被引：0
|
作者：
Augustsson, C. [1 ]
Persson, E. [1 ]
机构：
[1] Novo Nordisk AS, Bagsvaerd, Denmark
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：266 / 266
页数：1
相关论文
共 50 条
  • [1] Mechanism of action, development and clinical experience of recombinant FVIIa
    Hedner, Ulla
    JOURNAL OF BIOTECHNOLOGY, 2006, 124 (04) : 747 - 757
  • [2] Recombinant FVIIa
    Hedner, U
    VOX SANGUINIS, 2004, 87 : 25 - 28
  • [3] NOVEL PURE ANTIESTROGENS - MODE OF ACTION AND THERAPEUTIC PROSPECTS
    WAKELING, AE
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 595 : 348 - 356
  • [4] Novel Insights into the Mode of Action of Vasorelaxant Synthetic Polyoxygenated Chalcones
    Legeay, Samuel
    Tran, Kien
    Abatuci, Yannick
    Faure, Sebastien
    Helesbeux, Jean-Jacques
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (05)
  • [5] Gasotransmitters and the immune system: Mode of action and novel therapeutic targets
    Fagone, Paolo
    Mazzon, Emanuela
    Bramanti, Placido
    Bendtzen, Klaus
    Nicoletti, Ferdinando
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 834 : 92 - 102
  • [6] Off label use of recombinant FVIIa
    Hawk, S. E.
    Thompson, K. S.
    Plapp, F. V.
    TRANSFUSION, 2006, 46 (09) : 155A - 156A
  • [7] The Use of recombinant FVIIa in a structured massive transfusion protocol: A novel approach.
    Refaai, Majed A.
    Tchorz, Kathryn
    Forestner, John
    Morris, Raymond
    Koch, Marty
    Hampton, Scott
    Sarode, Ravindra
    BLOOD, 2006, 108 (11) : 115B - 115B
  • [8] STOPPING THE BLEEDING: THE ROLE OF RECOMBINANT FVIIA
    Boffard, K.
    SHOCK, 2012, 38 (04): : 18 - 19
  • [9] Recombinant FVIIa in the treatment of warfarin bleeding
    Berntorp, E
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04): : 433 - 435
  • [10] Therapeutic angiogenesis: novel insights in the mechanism of action of FGF-4
    Rubanyi, G. M.
    Basilico, C.
    HUMAN GENE THERAPY, 2015, 26 (10) : A5 - A5
12345